Russell H. Morgan Department of Radiology and Radiological Services, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA.
AJNR Am J Neuroradiol. 2012 May;33(5):852-7. doi: 10.3174/ajnr.A2895. Epub 2012 Jan 19.
Oligodendrogliomas are tumors that have variable WHO grades depending on anaplasia and astrocytic components and their treatment may differ accordingly. Our aim was to retrospectively evaluate imaging features of oligodendrogliomas that predict tumor grade.
The imaging studies of 75 patients with oligodendrogliomas were retrospectively reviewed and compared with the histologic grade. The presence and degree of enhancement and calcification were evaluated subjectively. rCBV and ADC maps were measured. Logistic linear regression models were used to determine the relationship between imaging factors and tumor grade.
Thirty of 75 (40%) tumors enhanced, including 9 of 46 (19.6%) grade II and 21 of 29 (72.4%) grade III tumors (P < .001). Grade III tumors showed lower ADC values compared with grade II tumors (odds ratio of a tumor being grade III rather than grade II = 0.07; 95% CI, 0.02-0.25; P = .001). An optimal ADC cutoff of 925 10(-6) mm(2)/s was established, which yielded a specificity of 89.1%, sensitivity of 62.1%, and accuracy of 78.7%. There was no statistically significant association between tumor grade and the presence of calcification and perfusion values. Multivariable prediction rules were applied for ADC < 925 10(-6) mm(2)/s, the presence of enhancement, and the presence of calcification. If either ADC < 925 10(-6) mm(2)/s or enhancement was present, it yielded 93.1% sensitivity, 73.9% specificity, and 81.3% accuracy. The most accurate (82.2%) predictive rule was seen when either ADC < 925 10(-6) mm(2)/s or enhancement and calcification were present.
Models based on contrast enhancement, calcification, and ADC values can assist in predicting the grade of oligodendrogliomas and help direct biopsy sites, raise suspicion of sampling error, and predict prognosis.
少突胶质细胞瘤的组织学分级取决于间变程度和星形细胞成分,其表现为不同的世界卫生组织分级,治疗方法也因此有所不同。本研究旨在回顾性分析少突胶质细胞瘤的影像学特征,以预测肿瘤分级。
回顾性分析了 75 例少突胶质细胞瘤患者的影像学资料,并与组织学分级进行比较。评估了增强程度和钙化程度。测量了 rCBV 和 ADC 图。采用逻辑线性回归模型确定影像学因素与肿瘤分级的关系。
75 例肿瘤中,30 例(40%)增强,其中 46 例 II 级肿瘤中有 9 例(19.6%),29 例 III 级肿瘤中有 21 例(72.4%)增强(P <.001)。III 级肿瘤的 ADC 值低于 II 级肿瘤(肿瘤为 III 级的几率比为 0.07;95%CI,0.02-0.25;P =.001)。确定了 ADC 最佳截断值为 925×10(-6)mm(2)/s,其特异性为 89.1%,敏感性为 62.1%,准确性为 78.7%。肿瘤分级与钙化和灌注值之间无统计学相关性。多变量预测规则适用于 ADC < 925×10(-6)mm(2)/s、增强和钙化。如果 ADC < 925×10(-6)mm(2)/s 或增强存在,其敏感性为 93.1%,特异性为 73.9%,准确性为 81.3%。当 ADC < 925×10(-6)mm(2)/s 或增强和钙化存在时,预测规则最准确(82.2%)。
基于对比增强、钙化和 ADC 值的模型可辅助预测少突胶质细胞瘤的分级,有助于指导活检部位,提高对取样误差的警惕性,并预测预后。